Skip to Content

GSK PLC GLAXF

Morningstar Rating
$21.00 +0.01 (0.05%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GLAXF is trading at a 12% discount.
Price
$20.94
Fair Value
$49.13
Uncertainty
High
1-Star Price
$81.65
5-Star Price
$36.46
Economic Moat
Kbfc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GLAXF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$20.99
Day Range
$20.5021.25
52-Week Range
$16.3421.50
Bid/Ask
$20.35 / $21.63
Market Cap
$85.22 Bil
Volume/Avg
9,201 / 2,309

Key Statistics

Price/Earnings (Normalized)
10.89
Price/Sales
2.29
Dividend Yield (Trailing)
3.50%
Dividend Yield (Forward)
4.87%
Total Yield
3.50%

Company Profile

In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Core
Total Number of Employees
70,212

Competitors

Valuation

Metric
GLAXF
MRK
PFE
Price/Earnings (Normalized)
10.8984.6314.45
Price/Book Value
4.908.551.69
Price/Sales
2.295.382.57
Price/Cash Flow
10.9121.2613.80
Price/Earnings
GLAXF
MRK
PFE

Financial Strength

Metric
GLAXF
MRK
PFE
Quick Ratio
0.590.680.58
Current Ratio
0.881.250.91
Interest Coverage
9.302.330.74
Quick Ratio
GLAXF
MRK
PFE

Profitability

Metric
GLAXF
MRK
PFE
Return on Assets (Normalized)
10.54%3.59%4.98%
Return on Equity (Normalized)
50.48%9.12%10.90%
Return on Invested Capital (Normalized)
21.33%5.88%7.28%
Return on Assets
GLAXF
MRK
PFE
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
LLY
Eli Lilly and CoSgtr$743.1 Bil
JNJ
Johnson & JohnsonTwz$390.5 Bil
MRK
Merck & Co IncVbsq$321.5 Bil
ABBV
AbbVie IncVrhbx$316.0 Bil
RHHBY
Roche Holding AG ADRHbvy$211.8 Bil
NVS
Novartis AG ADRDbf$208.3 Bil
AZN
AstraZeneca PLC ADRKyg$197.3 Bil
AMGN
Amgen IncZyt$150.2 Bil
PFE
Pfizer IncRbzvv$150.1 Bil
SNY
Sanofi SA ADRMnm$117.8 Bil

Sponsor Center